ABR-238901 [1638200-22-2]

MedChem Express

ABR-238901 [1638200-22-2]

10

1638200-22-2

Research Use Only

98.92

C11H9BrClN3O4S

394.63

ABR-238901 is an orally active and potent S100A8/A9 blocker and inhibits S100A8/A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll-like receptor 4). ABR-238901 has the potential for myocardial infarction (MI) research[1][2][3].

O=S(NC1=C(O)C(Cl)=CN=C1)(C2=CN=C(C(Br)=C2)OC)=O

-20°C, 3 years; 4°C, 2 years (Powder)

12352200